Craft
Strides Pharma

Strides Pharma

Revenue

₹30.2 B

FY, 2022

Market Capitalization

₹29.5 B

2023-01-20

Strides Pharma Summary

Company summary

Overview
Strides Pharma Science (formerly known as Strides Shasun) is a pharmaceutical company with a focus on the development and manufacture of IP-led niche finished dosage formulations. It is also engaged in the manufacturing of soft gelatin capsules.
Type
Public
Status
Active
Founded
1990
HQ
Bengaluru, IN | view all locations
Website
http://www.strides.com/
Cybersecurity rating
Sectors

Key people

  • Badree Komandur

    Badree Komandur, Executive Director & Group Chief Financial Officer

    • S. Sridhar

      S. Sridhar, Independent Director

      • Anjani Kumar

        Anjani Kumar, Chief Information Officer

        • Bharat Shah, Director

          LocationsView all

          5 locations detected

          • Bengaluru, KA HQ

            India

            Krishnaraju Layout, Amalodbhavi Nagar, Panduranga Nagar

          • East Brunswick, NJ

            United States

            2 Tower Center Blvd #1102

          • Lambertville, NJ

            United States

            201 S Main St #3

          • Navi Mumbai, MH

            India

            Devavrata Building, Palm Beach Rd, Sector 17, Vashi

          • Watford, England

            United Kingdom

            Unit 4 (side entrance, Metro Centre, Off Dwight Rd, Tolpits Ln

          Strides Pharma Financials

          Summary financials

          Revenue (FY, 2022)
          ₹30.2B
          Gross profit (FY, 2022)
          ₹14.9B
          Net income (FY, 2022)
          (₹4.7B)
          Cash (FY, 2022)
          ₹1.9B
          EBIT (FY, 2022)
          (₹5.9B)
          Enterprise value
          $57.9B

          Footer menu